Cancer Cells with Alternative Lengthening of Telomeres Do Not Display a General Hypersensitivity to ATR Inhibition.

about

ATR inhibitors as a synthetic lethal therapy for tumours deficient in ARID1A.The Role of ATRX in Glioma Biology.Directing the use of DDR kinase inhibitors in cancer treatment.Alternative lengthening of telomeres phenotype and loss of ATRX expression in sarcomas.

P2860

Q37508792-7F609CE2-B347-494F-BE87-DD0FF43EEDAC Q42369808-18BD7985-B927-46AB-9120-160DB7FECCF3 Q47687840-03CEC0D0-C1A5-45C0-8455-E5820B663A19 Q54985797-4E1DF378-6D12-4140-8405-C5F1FE8D704C

P2860

Cancer Cells with Alternative Lengthening of Telomeres Do Not Display a General Hypersensitivity to ATR Inhibition.

Item

http://www.wikidata.org/entity/Q41439061

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Cancer Cells with Alternative ...... sensitivity to ATR Inhibition.

@en

type

Item

label

Cancer Cells with Alternative ...... sensitivity to ATR Inhibition.

@en

prefLabel

Cancer Cells with Alternative ...... sensitivity to ATR Inhibition.

@en

P1476

Cancer Cells with Alternative ...... sensitivity to ATR Inhibition.

@en

P2093

Caroline Bauer

http://www.w3.org/2001/XMLSchema#string

Inn Chung

http://www.w3.org/2001/XMLSchema#string

Karsten Rippe

http://www.w3.org/2001/XMLSchema#string

Katharina I Deeg

http://www.w3.org/2001/XMLSchema#string

P2860

Cell cycle-dependent phosphorylation of the ATRX protein correlates with changes in nuclear matrix and chromatin association

Suppression of alternative lengthening of telomeres by Sp100-mediated sequestration of the MRE11/RAD50/NBS1 complex.

The SMC5/6 complex maintains telomere length in ALT cancer cells through SUMOylation of telomere-binding proteins

Functional significance of mutations in the Snf2 domain of ATRX.

Human MRE11 is inactivated in mismatch repair-deficient cancers.

Alternative lengthening of telomeres renders cancer cells hypersensitive to ATR inhibitors.

ATRX represses alternative lengthening of telomeres.

Role of Telomeres and Telomerase in Aging and Cancer.

Rapid induction of alternative lengthening of telomeres by depletion of the histone chaperone ASF1.

ATRX loss promotes tumor growth and impairs nonhomologous end joining DNA repair in glioma.

P304

186

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3389/FONC.2016.00186

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-08-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27602331

http://www.w3.org/2001/XMLSchema#string

P932

4993795

http://www.w3.org/2001/XMLSchema#string

Cancer Cells with Alternative Lengthening of Telomeres Do Not Display a General Hypersensitivity to ATR Inhibition.

about

P2860

P2860

Cancer Cells with Alternative Lengthening of Telomeres Do Not Display a General Hypersensitivity to ATR Inhibition.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P577

P698

P932